Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
From your lips to Gods ears!!
Huge Phase 3 5yr trials completed news released this morning. Could pull a double tomorrow in this tiny float coupled with the late Friday after close news!
Late Friday news keep on radar next week could go bonkers more news to follow?
Pomona Capital VII, L.P. has filed a new 13G, reporting 11.3% ownership in $NVCR - https://fintel.io/so/us/nvcr
* * $NVCR Video Chart 11-02-16 * *
Link to Video - click here to watch the technical chart video
No news makes for a boring company
What happened?
Headed to $9 imo
Wow what's happening-GREEN?
Novocure Converts More Than 500 U.S. Patients to Second Generation Optune within Four Weeks of FDA Approval on July 13
They still showed good improvement on the prescription base though. This company is funding many different trials right now....and earnings releases will dog this company for a while because of that. Until I see indications that
this novel approach to cancer is shy on meeting its endpoints, I'm in.
Analyst's lofty expectations drove this stock price down...not the actual performance of the product. Novel approaches to curing cancer are always met with skepticism, which automatically dictates a slow and steady build.
Analysts never pay attention to this reality.
Having a commercial product that is viable is huge. This keeps this company alive and in play for the foreseeable future.
I agree but the disconnect during quarterly earnings- 50% drops!!!!! This company had $29 IPO intentions and we sit at $7.50
going to be a lot of cash burn that will out pace revenues for at least 3 more years. Still.....it's a prove commercial technology. These would be the best levels to buy it at and check back in 2 years from now.
It won't be earnings releases that will bolster the share price anytime soon, rather an announcement that Medicare is coming on board, which is going to happen, and will be the biggest catalyst for this company.
That could happen in the next 18 months.
Not anymore lol. Terrible company execs-bloated pig
This company sucks and Doyle is awful
One thing I've learned about this company stock is it defies all logic.
Chart is looking great. Really enjoying this play- Quiet before the storm.
Very exciting times!
Looks like your ship may have just came in.
FDA APPROVAL MINUTES AGO. Technical and fundamentals lining up on this one!
Regardless, anywhere in this &10 range is a floor for the stock.
Yup and two weeks from now it will be Bullish. This stock is ridiculous
Great entry point today at 10.64.
This area is a strong floor for this stock.
Commercial stage drug company
With triple digit growth on no Invasive side effects and cash in the bank for next 12 mo this..... Count me in:)
No position currently
You still in this?
Don't fall in love now I'm beginning to hate this bitch
Going back to $30 and beyond $$
Go Go Go
Bet you guys wish you listened to me now $$$$
Everyone vacated here? I see this company going to $50+ in the coming years Jmho
Hmmmm I'm trying to decide if this is a buy right now-
IN at $12 - Looking to breakout - chart screaming buy!
Followers
|
28
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
550
|
Created
|
10/07/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |